Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory

Name: Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Health Canada is informing Canadians that the prescribing and patient information for Mifegymiso has been updated to reflect that an ultrasound is no longer required before the drug is prescribed. Mifegymiso is a combination product containing two drugs (mifepristone and misoprostol) that are taken in sequence for the medical termination of a pregnancy.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-11-01

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory (French, HTML) HTML
Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory (English, HTML) HTML

Related open data

Health Canada